X

Trial Profile

Evaluation of an Immunomodulatory Maintenance Treatment in Patients With Metastatic Colorectal Cancer With Tumor Reduction During Induction Treatment

Status: Active, no longer recruiting

Phase of Trial: Phase III

Latest Information Update: 06 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Lefitolimod (Primary)
Indications Colorectal cancer
Focus Registrational; Therapeutic Use
Acronyms IMPALA
Sponsors Mologen

Most Recent Events

22 May 2020 This trial has been Discontinued in United Kingdom according to European Clinical Trials Database record.
08 Apr 2020 This trial has been completed in Germany, according to European Clinical Trials Database record.
06 Oct 2019 This trial has been discontiued in Spain, according to European Clinical Trials Database record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com